Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEPTIN9 divergent transcript (SEPTIN9-DT) is a non-coding RNA gene transcribed from the region divergent to the SEPTIN9 protein-coding gene. Unlike the canonical SEPTIN9 gene, which encodes septin-9, a GTPase involved in cytoskeletal filament formation, cytokinesis, and implicated as a tumor suppressor and cancer biomarker[4][5], the function, biological relevance, and potential disease associations of SEPTIN9-DT remain uncharacterized in current scientific databases and literature[1]. There is no evidence supporting its consideration as a therapeutic target, biomarker, or druggable molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEPTIN9 divergent transcript (SEPTIN9-DT).